Cargando…

Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7–8, 2022

Policymakers often rely on impact and cost-effectiveness evaluations to inform decisions about the introduction of health interventions in low- and middle-income countries (LMICs); however, cost-effectiveness results for the same health intervention can differ by the choice of parameter inputs, mode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fitzpatrick, Meagan C., Laufer, Rachel S., Baral, Ranju, Driscoll, Amanda J., Feikin, Daniel R., Fleming, Jessica A., Jit, Mark, Kim, Sonnie, Koltai, Mihaly, Li, You, Li, Xiao, Nair, Harish, Neuzil, Kathleen M., Pecenka, Clint, Sparrow, Erin, Srikantiah, Padmini, Ortiz, Justin R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2023
Materias:	WHO Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680976/ https://www.ncbi.nlm.nih.gov/pubmed/37777450 http://dx.doi.org/10.1016/j.vaccine.2023.09.040

Ejemplares similares

Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
por: Mahmud, Sarwat, et al.
Publicado: (2023)

Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort model
por: Baral, Ranju, et al.
Publicado: (2021)

Association of Childless Couples Of Ghana (ACCOG)
por: Yaw Osei, N.
Publicado: (2014)

MRC Maternal and Infant Health Care Strategies Research Unit
por: Pattinson, R.C.
Publicado: (2010)

Introduction to Who’s Who: EBCOG
por: Van Wiemeersch, J.
Publicado: (2010)

EBCOG: European Board and College of Obstetrics and Gynaecology: Who are we? What do we do? Where do we go?
por: Hornnes, P., et al.
Publicado: (2010)

ENTOG, European Network of Trainees in Obstetrics and Gynaecology
por: Martins, N., et al.
Publicado: (2010)

EBCOG Hospital Recognition: where do we stand?
por: Wladimiroff, J., et al.
Publicado: (2010)

ISMAAR: The International Society for Mild Approaches in Assisted Reproduction
por: Nargund, G.
Publicado: (2011)

Global Work of the International Federation of Gynecology and Obstetrics (FIGO)
por: Serour, G.I.
Publicado: (2012)

The Walking Egg non-profit organisation
por: Dhont, N.
Publicado: (2011)

International Centre for Reproductive Health (ICRH): An international multidisciplinary centre of excellence in the field of reproductive health
por: Claeys, P., et al.
Publicado: (2011)

Swasti: An International Health Resource Centre
por: Kumar, N.S.
Publicado: (2013)

Who's Who
Publicado: (2020)

The Walking Egg non-profit organization
por: Ombelet, W, et al.
Publicado: (2019)

Who's Who
Publicado: (2021)

Who's Who
Publicado: (2021)

Who’s Who
Publicado: (2022)

Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions
por: Laufer, Rachel S., et al.
Publicado: (2021)

Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in Malawi
por: Baral, Ranju, et al.
Publicado: (2020)

Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis
por: Laufer, Rachel S., et al.
Publicado: (2023)

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective
por: Wittenauer, Rachel, et al.
Publicado: (2023)

Lessons learned from the Advancing Maternal Immunization collaboration: identifying evidence gaps for informed respiratory syncytial virus maternal immunization decision-making
por: Groman, Devin, et al.
Publicado: (2019)

Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverage
por: Baral, Ranju, et al.
Publicado: (2020)

Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization
por: Feikin, Daniel R., et al.
Publicado: (2023)

WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use
por: Sparrow, Erin, et al.
Publicado: (2022)

Lofty goals at high altitude: The Grover Conferences, 1984–2011
por: Weir, E. Kenneth, et al.
Publicado: (2011)

The herd shot “round the world”
por: Grover, Robert F.
Publicado: (2012)

The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models
por: Baral, Ranju, et al.
Publicado: (2020)

Respiratory syncytial virus: promising progress against a leading cause of pneumonia
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021)

Improving the selection and development of influenza vaccine viruses – Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18–20 November 2015
por: Alan, Hampson, et al.
Publicado: (2017)

New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants
por: Srikantiah, Padmini, et al.
Publicado: (2023)

Assessing the Full Burden of Respiratory Syncytial Virus in Young Infants in Low- and Middle-Income Countries: The Importance of Community Mortality Studies
por: Srikantiah, Padmini, et al.
Publicado: (2021)

WHO consultation sets research priorities for monkeypox
Publicado: (2022)

Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates
por: Baral, Ranju, et al.
Publicado: (2020)

Respiratory Syncytial Virus (RSV) Disease and Prevention Products: Knowledge, Attitudes, and Preferences of Kenyan Healthcare Workers in Two Counties in 2021
por: Nyawanda, Bryan O., et al.
Publicado: (2023)

Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence
por: Ortiz, Justin R., et al.
Publicado: (2023)

Placebo use in vaccine trials: Recommendations of a WHO expert panel
por: Rid, Annette, et al.
Publicado: (2014)

Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group
por: Jamrozik, Euzebiusz, et al.
Publicado: (2021)

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3g9bf0bg0fm1i04ks38uutlvlg